Advances on the roles of tenascin-C in cancer

Author:

Yilmaz Alev123ORCID,Loustau Thomas123ORCID,Salomé Nathalie123,Poilil Surendran Suchithra123,Li Chengbei123,Tucker Richard P.4ORCID,Izzi Valerio56ORCID,Lamba Rijuta56ORCID,Koch Manuel78ORCID,Orend Gertraud123ORCID

Affiliation:

1. The Tumor Microenvironment Laboratory, INSERM U1109, Hôpital Civil, Institut d'Hématologie et d'Immunologie 1 , 1 Place de l'Hôpital, 67091 Strasbourg , France

2. Université Strasbourg 2 , 67000 Strasbourg , France

3. Fédération de Médecine Translationnelle de Strasbourg (FMTS) 3 , 67000 Strasbourg , France

4. University of California at Davis 4 Department of Cell Biology and Human Anatomy , , 95616 Davis, CA , USA

5. University of Oulu 5 Faculty of Biochemistry and Molecular Medicine , , FI-90014 Oulu , Finland

6. University of Oulu 6 Faculty of Medicine , , FI-90014 Oulu , Finland

7. Institute for Dental Research and Oral Musculoskeletal Research, Center for Biochemistry, Center for Molecular Medicine Cologne (CMMC) 7 , Faculty of Medicine and , Joseph-Stelzmann-Str. 52, 50931 Cologne , Germany

8. University Hospital Cologne, University of Cologne 7 , Faculty of Medicine and , Joseph-Stelzmann-Str. 52, 50931 Cologne , Germany

Abstract

ABSTRACT The roles of the extracellular matrix molecule tenascin-C (TNC) in health and disease have been extensively reviewed since its discovery over 40 years ago. Here, we will describe recent insights into the roles of TNC in tumorigenesis, angiogenesis, immunity and metastasis. In addition to high levels of expression in tumors, and during chronic inflammation, and bacterial and viral infection, TNC is also expressed in lymphoid organs. This supports potential roles for TNC in immunity control. Advances using murine models with engineered TNC levels were instrumental in the discovery of important functions of TNC as a danger-associated molecular pattern (DAMP) molecule in tissue repair and revealed multiple TNC actions in tumor progression. TNC acts through distinct mechanisms on many different cell types with immune cells coming into focus as important targets of TNC in cancer. We will describe how this knowledge could be exploited for cancer disease management, in particular for immune (checkpoint) therapies.

Funder

Institut National de la Santé et de la Recherche Médicale

Agence Nationale de la Recherche

Ligue contre le cancer

Academy of Finland

University of Oulu

Finnish Cancer Institute

Deutsche Forschungsgemeinschaft

Chinese Scholarship Council

Publisher

The Company of Biologists

Subject

Cell Biology

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3